Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by valueplaysonlyon Jun 06, 2013 8:16pm
56 Views
Post# 21494894

RE: RE: Again I ask the question

RE: RE: Again I ask the question

   If the result was only  marginal   improvement        and no where  near the threshold hoped for,  then   the stock  could have dropped a dollar  and not  have been totally wiped out   .  These stocks  are risky.  Look at chart for Thera Technologies over the last 10   years.

The drop  combined with   big volume suggests to  me some sort of a leak   took  place within the Cleveland Clinic .  And do not think   for a second that the worlds trades on impartial and   fair information.  It does     not and never will. 

And the fact that  there was no   "bounce  back"   the last two days   is an  ominous sign  .  Whats the reason?SPINCO    tops is worth  a quarter as a germination seed   ten years  before any meaningful  test results  .  My question to the informed   is  what  constitutes   the other   50 cent drop  after holding the  360 range for a decently   long time?

Some  value plays  are    admittedly riskier than   others.    With over 8 take overs in energy services the last two  years   CEZ   is  a value play  that carries  no  risk.

 

 

 

Bullboard Posts